Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance
ClinicalTrials.gov study NCT03267654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients
ClinicalTrials.gov study NCT02226757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT02192697. IPD Sharing: YES. Countries: 3. Publications: 0.
H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC
ClinicalTrials.gov study NCT05552781. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations
ClinicalTrials.gov study NCT01470716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
ClinicalTrials.gov study NCT02726568. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05166616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2
ClinicalTrials.gov study NCT06074588. IPD Sharing: YES. Countries: 25. Publications: 0.
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT05241873. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC
ClinicalTrials.gov study NCT06962865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05991193. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT01746251. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases
ClinicalTrials.gov study NCT05768490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT04044170. IPD Sharing: Not stated. Countries: 2. Publications: 0.
High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation
ClinicalTrials.gov study NCT02404675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative
ClinicalTrials.gov study NCT03758287. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene
ClinicalTrials.gov study NCT01221077. IPD Sharing: NO. Countries: 6. Publications: 0.
A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain Metastasis
ClinicalTrials.gov study NCT06945705. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations
ClinicalTrials.gov study NCT01410214. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations
ClinicalTrials.gov study NCT03529084. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.